Patients and plaintiffs lawyers argue that Novo Nordisk failed to warn prescribing physicians and patients about the risks of delayed gastric emptying and other serious side effects
GHK-Cu peptide has been researched for its potential across a variety of functions (1) including that it may tighten and reverse the thinning of aging skin structure, supporting the extracellular matrix, that it may restore the skin barrier and moderate texture, hyperpigmentation and lesions, may support tissue repair and mitigate inflammation, may stimulate increasing hair follicle size, may exert antioxidant properties and, finally, may exhibit gene restructuring potential
The trial was stopped early due to clear evidence of renal protection, in order to give the placebo group access to the potentially life saving medication
found the prevalence of Salmonella contamination to be less than 1%
Kato K, Kleinhenz JM, Shin Y-J, Coarfa C, Zarrabi AJ, Hecker L
3 BaiL.MesgarzadehS.RameshK